Epidemiology and Immunopathogenesis of Virus Associated Asthma Exacerbations

Agamemnon Bakakos, Zoi Sotiropoulou, Angelos Vontetsianos, Stavroula Zaneli, Andriana I Papaioannou, Petros Bakakos 1st University Department of Respiratory Medicine, National and Kapodistrian University of Athens, Athens, 11527, GreeceCorrespondence: Agamemnon Bakakos, 1st University Department of...

Full description

Bibliographic Details
Main Authors: Bakakos A, Sotiropoulou Z, Vontetsianos A, Zaneli S, Papaioannou AI, Bakakos P
Format: Article
Language:English
Published: Dove Medical Press 2023-09-01
Series:Journal of Asthma and Allergy
Subjects:
Online Access:https://www.dovepress.com/epidemiology-and-immunopathogenesis-of-virus-associated-asthma-exacerb-peer-reviewed-fulltext-article-JAA
_version_ 1797672965021630464
author Bakakos A
Sotiropoulou Z
Vontetsianos A
Zaneli S
Papaioannou AI
Bakakos P
author_facet Bakakos A
Sotiropoulou Z
Vontetsianos A
Zaneli S
Papaioannou AI
Bakakos P
author_sort Bakakos A
collection DOAJ
description Agamemnon Bakakos, Zoi Sotiropoulou, Angelos Vontetsianos, Stavroula Zaneli, Andriana I Papaioannou, Petros Bakakos 1st University Department of Respiratory Medicine, National and Kapodistrian University of Athens, Athens, 11527, GreeceCorrespondence: Agamemnon Bakakos, 1st University Department of Respiratory Medicine, National and Kapodistrian University of Athens, Kononos 11 Street, Athens, 11634, Greece, Tel +306972455781, Email agabak@hotmail.comAbstract: Asthma is a common airway disease, affecting millions of people worldwide. Although most asthma patients experience mild symptoms, it is characterized by variable airflow limitation, which can occasionally become life threatening in the case of a severe exacerbation. The commonest triggers of asthma exacerbations in both children and adults are viral infections. In this review article, we will try to investigate the most common viruses triggering asthma exacerbations and their role in asthma immunopathogenesis, since viral infections in young adults are thought to trigger the development of asthma either right away after the infection or at a later stage of their life. The commonest viral pathogens associated with asthma include the respiratory syncytial virus, rhinoviruses, influenza and parainfluenza virus, metapneumovirus and coronaviruses. All these viruses exploit different molecular pathways to infiltrate the host. Asthmatics are more prone to severe viral infections due to their unique inflammatory response, which is mostly characterized by T2 cytokines. Unlike the normal T1 high response to viral infection, asthmatics with T2 high inflammation are less potent in containing a viral infection. Inhaled and/or systematic corticosteroids and bronchodilators remain the cornerstone of asthma exacerbation treatment, and although many targeted therapies which block molecules that viruses use to infect the host have been used in a laboratory level, none has been yet approved for clinical use. Nevertheless, further understanding of the unique pathway that each virus follows to infect an individual may be crucial in the development of targeted therapies for the commonest viral pathogens to effectively prevent asthma exacerbations. Finally, biologic therapies resulted in a complete change of scenery in the treatment of severe asthma, especially with a T2 high phenotype. All available data suggest that monoclonal antibodies are safe and able to drastically reduce the rate of viral asthma exacerbations.Keywords: asthma, virus, exacerbation, pathogenesis, lungs
first_indexed 2024-03-11T21:37:46Z
format Article
id doaj.art-6c223bce8b2e4bd89b5b8cf4846e8638
institution Directory Open Access Journal
issn 1178-6965
language English
last_indexed 2024-03-11T21:37:46Z
publishDate 2023-09-01
publisher Dove Medical Press
record_format Article
series Journal of Asthma and Allergy
spelling doaj.art-6c223bce8b2e4bd89b5b8cf4846e86382023-09-26T18:27:38ZengDove Medical PressJournal of Asthma and Allergy1178-69652023-09-01Volume 161025104086951Epidemiology and Immunopathogenesis of Virus Associated Asthma ExacerbationsBakakos ASotiropoulou ZVontetsianos AZaneli SPapaioannou AIBakakos PAgamemnon Bakakos, Zoi Sotiropoulou, Angelos Vontetsianos, Stavroula Zaneli, Andriana I Papaioannou, Petros Bakakos 1st University Department of Respiratory Medicine, National and Kapodistrian University of Athens, Athens, 11527, GreeceCorrespondence: Agamemnon Bakakos, 1st University Department of Respiratory Medicine, National and Kapodistrian University of Athens, Kononos 11 Street, Athens, 11634, Greece, Tel +306972455781, Email agabak@hotmail.comAbstract: Asthma is a common airway disease, affecting millions of people worldwide. Although most asthma patients experience mild symptoms, it is characterized by variable airflow limitation, which can occasionally become life threatening in the case of a severe exacerbation. The commonest triggers of asthma exacerbations in both children and adults are viral infections. In this review article, we will try to investigate the most common viruses triggering asthma exacerbations and their role in asthma immunopathogenesis, since viral infections in young adults are thought to trigger the development of asthma either right away after the infection or at a later stage of their life. The commonest viral pathogens associated with asthma include the respiratory syncytial virus, rhinoviruses, influenza and parainfluenza virus, metapneumovirus and coronaviruses. All these viruses exploit different molecular pathways to infiltrate the host. Asthmatics are more prone to severe viral infections due to their unique inflammatory response, which is mostly characterized by T2 cytokines. Unlike the normal T1 high response to viral infection, asthmatics with T2 high inflammation are less potent in containing a viral infection. Inhaled and/or systematic corticosteroids and bronchodilators remain the cornerstone of asthma exacerbation treatment, and although many targeted therapies which block molecules that viruses use to infect the host have been used in a laboratory level, none has been yet approved for clinical use. Nevertheless, further understanding of the unique pathway that each virus follows to infect an individual may be crucial in the development of targeted therapies for the commonest viral pathogens to effectively prevent asthma exacerbations. Finally, biologic therapies resulted in a complete change of scenery in the treatment of severe asthma, especially with a T2 high phenotype. All available data suggest that monoclonal antibodies are safe and able to drastically reduce the rate of viral asthma exacerbations.Keywords: asthma, virus, exacerbation, pathogenesis, lungshttps://www.dovepress.com/epidemiology-and-immunopathogenesis-of-virus-associated-asthma-exacerb-peer-reviewed-fulltext-article-JAAasthmavirusexacerbationpathogenesislungs
spellingShingle Bakakos A
Sotiropoulou Z
Vontetsianos A
Zaneli S
Papaioannou AI
Bakakos P
Epidemiology and Immunopathogenesis of Virus Associated Asthma Exacerbations
Journal of Asthma and Allergy
asthma
virus
exacerbation
pathogenesis
lungs
title Epidemiology and Immunopathogenesis of Virus Associated Asthma Exacerbations
title_full Epidemiology and Immunopathogenesis of Virus Associated Asthma Exacerbations
title_fullStr Epidemiology and Immunopathogenesis of Virus Associated Asthma Exacerbations
title_full_unstemmed Epidemiology and Immunopathogenesis of Virus Associated Asthma Exacerbations
title_short Epidemiology and Immunopathogenesis of Virus Associated Asthma Exacerbations
title_sort epidemiology and immunopathogenesis of virus associated asthma exacerbations
topic asthma
virus
exacerbation
pathogenesis
lungs
url https://www.dovepress.com/epidemiology-and-immunopathogenesis-of-virus-associated-asthma-exacerb-peer-reviewed-fulltext-article-JAA
work_keys_str_mv AT bakakosa epidemiologyandimmunopathogenesisofvirusassociatedasthmaexacerbations
AT sotiropoulouz epidemiologyandimmunopathogenesisofvirusassociatedasthmaexacerbations
AT vontetsianosa epidemiologyandimmunopathogenesisofvirusassociatedasthmaexacerbations
AT zanelis epidemiologyandimmunopathogenesisofvirusassociatedasthmaexacerbations
AT papaioannouai epidemiologyandimmunopathogenesisofvirusassociatedasthmaexacerbations
AT bakakosp epidemiologyandimmunopathogenesisofvirusassociatedasthmaexacerbations